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Whereas in decades past, hysterectomy was seen almost
as a panacea for any uterine affliction, including leiomy-
omas [1], attention has been paid more recently to the
development of pharmaceutical agents (medical treat-
ment) [2–4] and procedures that are less invasive [5,6]
or that are performed by routes that incur less morbidity
than conventional laparotomy [7]. Frequently, such
procedures are designed to retain the uterus. Therefore,
organ-preserving intervention has become more and
more popular [8]. Myomectomy may be one of the
most frequently used strategies in the management of
women with symptomatic uterine myomas [9]. However,
malignant-type leiomyosarcomas should be kept in mind
during the pathologic review, although the incidence is
rare and the majority of leiomyosarcomas are diagnosed
after hysterectomy or myomectomy [10,11]. Here, we
present a case of leiomyosarcoma diagnosed from a
myomectomy specimen from a 48-year-old woman.
A 48-year-old female, gravida 3, para 2, abortus 1,
with a diagnosis of leiomyosarcoma based on a myomec-
tomy specimen obtained through ultra-minilaparotomy
(UML) [12], delayed undergoing complete staging
surgery for 1 month for personal reasons. Computed
tomography before the staging surgery failed to detect
an abnormality. Operative findings showed a 2-cm par-
asitic mass located in the vesicouterine space, and a
well-healed uterus. Complete staging surgery, including
total hysterectomy, bilateral salpingo-oophorectomy,
lymph node sampling and multiple random biopsies,
was performed. The final pathology showed no resid-
ual malignant tumor within the uterus, except for the
diagnosis of a metastatic leiomyosarcoma on the above-
mentioned mass. Postoperative adjuvant pelvic radia-
tion with 2,800 cGy was given. At the time of writing,
the patient had been well and without recurrent disease
for more than 3 years.
Three important issues arise in this case report.
One is how to distinguish between a leiomyoma and a
leiomyosarcoma prior to the use of organ preservation
therapy, including myomectomy. Although many imag-
ing studies, including high-resolution ultrasound, com-
puted tomography and magnetic resonance imaging,
or even positron emission tomography, have been tried,
none of them can achieve satisfactory sensitivity or speci-
ficity, partly because of the small sample size [11,13].
Second, what is the next step when patients are diagno-
sed with leiomyosarcoma on a myomectomy specimen?
Here, there is little doubt; hysterectomy and bilateral
salpingo-oophorectomy are considered the standard
therapy for leiomyosarcoma of the uterus [14]. How-
ever, for young nulliparous women desiring pregnancy,
clearly the patient and family must both be made
aware of the problem and be involved in the final deci-
sion [15]. A strict follow-up and an obliterative proce-
dure at the completion of reproductive life may be a
viable alternative if the patient understands and accepts
the risk [15]. Third, the physician must be aware of the
potential occurrence of parasitic leiomyosarcoma or
leiomyomatosis after myomectomy, because procedures
that are less invasive than hysterectomy or exploratory
laparotomy myomectomy can be used [15]. The real
cause of disseminated leiomyomatosis is not fully under-
stood, but it is believed to spread iatrogenically during
surgery [16]. That is why there are more cases reported
after myomectomy, especially laparoscopy and mor-
cellation [17]. In this case, the appearance of para-
sitic leiomyosarcomas could be explained by pieces of
myometrial tissue being left behind in the peritoneal
cavity during myomectomy using the UML approach.
In addition, rapid growth and dissemination of leio-
myosarcomas can occur very soon after the original
operation if it is incomplete, hinting that conservative
therapy should be used with caution. However, no
residual malignant leiomyosarcoma was found in the
hysterectomy specimen in this case, which further 
supported the finding of previous studies that the
acceptability of UML for myomectomy might be simi-
lar to that of conventional exploratory laparotomy for
myomectomy [5,7].
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We conclude that iatrogenic metastasis of leio-
myosarcoma with rapid growth may occur in women
who are treated with UML myomectomy, and re-staging
surgery is recommended in these patients.
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